Exact Mass: 510.0767

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

Leinamycin

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

2-O-[2-O-(alpha-D-Mannopyranosyl)-alpha-D-glucopyranosyl]-3-phospho-D-glycerate

2-O-[alpha-D-mannopyranosyl-(1->2)-alpha-D-glucopyranosyl]-3-O-phospho-D-glyceric acid

C15H27O17P (510.0986)

Daidzein 4'-glucuronide-7-sulfate

(2R,4R,6R)-3,4,5-Trihydroxy-6-{4-[4-oxo-7-(sulphooxy)-4H-chromen-3-yl]phenoxy}oxane-2-carboxylic acid

Daidzein 7-glucuronide-4'-sulfate

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-({4-oxo-3-[4-(sulfooxy)phenyl]-4H-chromen-7-yl}oxy)oxane-2-carboxylic acid

cefuroxime axetil

1-{3-[(carbamoyloxy)methyl]-7-[2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carbonyloxy}ethyl acetate

IB-Meca

3,4-Dihydroxy-5-(6-{[(3-iodophenyl)methyl]amino}-9H-purin-9-yl)-N-methyloxolane-2-carboximidate

Lormetazepam glucuronide

6-{[7-chloro-5-(2-chlorophenyl)-1-methyl-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C22H20Cl2N2O8 (510.0597)

3,3,4,5,5,7,8-heptahydroxyl flavone-8-O-beta-D-glucuronopyranoside|floramanoside C

C21H18O15 (510.0646)

pseudonocardone

C26H22O11 (510.1162)

4,4-Pyranose-1,3-Hexahydroxydiphenoylglucose

C22H22O14 (510.101)

NSC289645

C25H18O12 (510.0798)

Citicoline

2-(((((((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)-N,N,N-trimethylethan-1-aminium, sodium salt(1:1)

C14H25N4NaO11P2 (510.0893)

Donor of choline in biosynthesis of choline-containing phosphoglycerides.

3-Methyl-1-hydroxybutyl-TPP

3-Methyl-1-hydroxybutyl-ThPP

C17H28N4O8P2S (510.1103)

2-Methyl-1-hydroxybutyl-TPP

2-Methyl-1-hydroxybutyl-ThPP

C17H28N4O8P2S (510.1103)

sodium,formaldehyde,4-(4-hydroxyphenyl)sulfonylphenol,naphthalene-1-sulfonate

C23H19NaO8S2 (510.0419)

8-Chloro-4-[(3-chloro-4-fluorophenyl)amino]-6-({[1-(4-piperidinyl )-1H-1,2,3-triazol-4-yl]methyl}amino)-3-quinolinecarbonitrile

C24H21Cl2FN8 (510.125)

1H,1H,2H,2H-PERFLUOROOCTYLTRIETHOXYSILANE

C14H19F13O3Si (510.0896)

3-(2-Pyridyl)-5,6-diphenyl-1,2,4-triazine-p,p′-disulfonic acid monosodium salt hydrate

C20H15N4NaO7S2 (510.028)

Glicetanile

C23H24ClN4NaO4S (510.1104)

IB-MECA

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Piclidenoson (IB-MECA) is a first-in-class, orally active and selective A3 adenosine receptor (A3AR) agonist. Piclidenoson exhibits antiproliferative effect and induces apoptosis in different cancer cell types like melanoma, leukemia. Piclidenoson can be used for the research of autoimmune inflammatory diseases and COVID-19[1][2][3][4].

sodium,formaldehyde,4-(4-hydroxyphenyl)sulfonylphenolate,naphthalene-1-sulfonic acid

C23H19NaO8S2 (510.0419)

450191S

C21H21Cl3N6O3 (510.0741)

Rilmazafone hydrochloride (450191S) is a benzodiazepine (omega) ligand[1].

bis(4-propan-2-ylphenyl)iodanium,hexafluorophosphate

C18H22F6IP (510.0408)

Triphenylbismuth dichloride

Dichloro(triphenyl)-λ5-bismuthane

C18H15BiCl2 (510.0355)

9,9-BIS(4-TRIFLUOROVINYLOXYPHENYL)FLUORENE

C29H16F6O2 (510.1054)

Phosphoric trichloride, polymer with 1,3-benzenediol, phenyl ester

C30H24O4P2 (510.115)

Uridine, 4-thio-, 5-acetate 2,3-dibenzoate (9CI)

C25H22N2O8S (510.1097)

Δ2-CefuroxiMe Axetil

Iodoacetyl-LC-biotin

C18H31IN4O3S (510.1162)

2,4-Dinitrophenyl-2-deoxy-2-fluoro-beta-D-cellobioside

C18H23FN2O14 (510.1133)

2-[2-(2,4-dichloro-5-propan-2-yloxyanilino)-2-oxoethyl]sulfinyl-N-[3-(trifluoromethyl)phenyl]acetamide

C20H19Cl2F3N2O4S (510.0395)

N-[[3-(4-methylphenyl)sulfonyl-2-oxazolidinyl]methyl]-N-[2-(4-sulfamoylphenyl)ethyl]oxamide

C21H26N4O7S2 (510.1243)

Citicoline sodium

C14H25N4NaO11P2 (510.0893)

N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018697 - Nootropic Agents

Lormetazepam glucuronide

6-{[7-chloro-5-(2-chlorophenyl)-1-methyl-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C22H20Cl2N2O8 (510.0597)

dehydro coenzyme F420-0

C19H17N3O12P-3 (510.055)

Zinnat

cefuroxime axetil

Daidzein 4-glucuronide-7-sulfate

(2S,3R,5R)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-N-methyl-2-oxolanecarboxamide

3-L-tyrosyl-AMP

C19H23N6O9P (510.1264)

An L-tyrosyl ester obtained by formal condensation of the carboxy group of L-tyrosine with the 3-hydroxy group of AMP.

bis[2-(3-chloro-4-methoxyanilino)-2-oxoethyl] (E)-but-2-enedioate

C22H20Cl2N2O8 (510.0597)

(5E)-3-(4-ethoxyphenyl)-5-(3-hydroxy-4-methoxybenzylidene)-2-(3-nitrophenyl)-1,3-thiazolidin-4-one 1,1-dioxide

C25H22N2O8S (510.1097)

1-(4-Chloro-3-fluorophenyl)-3-[[4-[[(4-chloro-3-fluorophenyl)carbamothioylamino]methyl]phenyl]methyl]thiourea

C22H18Cl2F2N4S2 (510.0318)

7-Hydroxy-8-{[4-(phenyldiazenyl)phenyl]diazenyl}naphthalene-1,3-disulfonate

C22H14N4O7S2-2 (510.0304)

2-[(2-Hydroxynaphthalen-1-yl)diazenyl]-5-[(4-sulfonatophenyl)diazenyl]benzene-1-sulfonate

C22H14N4O7S2-2 (510.0304)

3,4,5-Trihydroxy-6-[[3,6,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxo-2,3-dihydrochromen-5-yl]oxy]oxane-2-carboxylic acid

C22H22O14 (510.101)

Cefmenoxime(1-)

C16H16N9O5S3- (510.0437)

The anion of cefmenoxime.

3,4,5-Trihydroxy-6-[2-hydroxy-4-(3,5,7-trihydroxy-6-methoxy-4-oxo-2,3-dihydrochromen-2-yl)phenoxy]oxane-2-carboxylic acid

C22H22O14 (510.101)

2-O-[alpha-D-mannopyranosyl-(1->2)-alpha-D-glucopyranosyl]-3-O-phospho-D-glyceric acid

C15H27O17P (510.0986)

3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-N-methyl-2-oxolanecarboxamide

Daidzein 7-glucuronide-4-sulfate

Citicoline (sodium)

C14H25N4NaO11P2 (510.0893)

Citicoline sodium salt is an intermediate in the synthesis of phosphatidylcholine which is a component of cell membranes and also exerts neuroprotective effects. Citicoline sodium salt is an intermediate in the synthesis of phosphatidylcholine which is a component of cell membranes and also exerts neuroprotective effects.

(9z,13z,15z)-3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate

(2z)-n-[(6r,7r)-2-{[1-(acetyloxy)ethoxy]carbonyl}-3-[(c-hydroxycarbonimidoyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-7-yl]-2-(furan-2-yl)-2-(methoxyimino)ethanimidic acid

3,4,5-trihydroxy-6-[(1-hydroxy-8-methoxy-3-methyl-7,12-dioxotetraphen-2-yl)oxy]oxane-2-carboxylic acid

C26H22O11 (510.1162)

4,11-dihydroxy-12-{11-hydroxy-10-oxo-8,16-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,11,13,15-octaen-12-yl}-8,16-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,11,13,15-octaen-10-one

4,11-dihydroxy-12-{11-hydroxy-10-oxo-8,16-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,11,13,15-octaen-12-yl}-8,16-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,11,13,15-octaen-10-one

C30H14N4O5 (510.0964)

6,9,10-trihydroxy-19,20-dimethoxy-23-methyl-4,22-dioxa-13,14-dithia-3,23-diazahexacyclo[10.10.2.0¹,¹⁵.0³,¹².0⁵,¹⁰.0¹⁶,²¹]tetracosa-7,16,18,20-tetraene-2,24-dione

C21H22N2O9S2 (510.0767)

10',11',14'-trihydroxy-7-methoxy-6'-methyl-3,8'-bis(methylsulfanyl)-3h-2'-oxa-3',6'-diazaspiro[1-benzofuran-2,5'-tricyclo[8.4.0.0³,⁸]tetradecan]-12'-ene-4',7'-dione

C22H26N2O8S2 (510.1131)

(1r,5s,6r,9r,10s,12r,15r)-6,9,10-trihydroxy-19,20-dimethoxy-23-methyl-4,22-dioxa-13,14-dithia-3,23-diazahexacyclo[10.10.2.0¹,¹⁵.0³,¹².0⁵,¹⁰.0¹⁶,²¹]tetracosa-7,16,18,20-tetraene-2,24-dione

(1r,5s,6r,9r,10s,12r,15r)-6,9,10-trihydroxy-19,20-dimethoxy-23-methyl-4,22-dioxa-13,14-dithia-3,23-diazahexacyclo[10.10.2.0¹,¹⁵.0³,¹².0⁵,¹⁰.0¹⁶,²¹]tetracosa-7,16,18,20-tetraene-2,24-dione

C21H22N2O9S2 (510.0767)

(1'r,2r,3'r,6s,9e,11r,13z,15e)-3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate

(2r,3'r,6r,9e,11r,13e,15z)-3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate

(2r,3'r,6r,9z,11r,13z,15e)-3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate

(1's,2r,3r,8'r,10's,11'r,14'r)-10',11',14'-trihydroxy-7-methoxy-6'-methyl-3,8'-bis(methylsulfanyl)-3h-2'-oxa-3',6'-diazaspiro[1-benzofuran-2,5'-tricyclo[8.4.0.0³,⁸]tetradecan]-12'-ene-4',7'-dione

C22H26N2O8S2 (510.1131)

(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(1-hydroxy-8-methoxy-3-methyl-7,12-dioxotetraphen-2-yl)oxy]oxane-2-carboxylic acid

C26H22O11 (510.1162)

3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate